Document Page: First | Prev | Next | All | Image | This Release | Search

File: 011696_44_17_004.txt
Page: 004
Total Pages: 6




                                           UNCLASSIFIED



       04 06 22120OZ OCT 90 RR RR UUUU                              2931120



       THE SIDE EFFECTS FROM ADMINISTERING CANA WITHOUT BEING EXPOSED TO

       NERVE AGENT ARE MINIMAL (IMPAIRED VISUAL TRACKING AND

       DECISION MAKING ABILITY FOR TWO TO FIVE HOURS). THERE IS NO RISK OF

       PROLONGED INCAPACITION OR ADDICTION WITH A SINGLE UNAUTHORIZED

       INJECTION.

       3.   SINCE CANA CONTAINS A CDNTROLLED SUBSTANCE, ABLES IT NOWHERE IN

       THE SAME CATEGORY AS A NARCOTIC, COMPONENT COMMANDERS WILL ENSURE

       ACCOUNTABILITY FOR IT WHEN ISSUED. THIS WILL BE ACCOMPLISHED THROUGH

       LOG BOOKS OR FORMS SIMILAR TO THOSE USED TO ISSUE WEAPONS OR

       ORGANIZATIONAL CLOTHING AND EQUIPMENT. FURTHERMORE, INDIVIDUALS

       MUST ATTEND A CLASS FOR ADMINISTERING FIRST AID TO A NERVE AGENT

       CASUALTY BEFORE BEING ISSUED THE CANA.

       4.   THE INSTRUCTION WILL BE AN UPDATE OF THE BASIC FIRST-AID FOR A

       NERVE AGENT CASUALTY THAT WILL INCORPORATE CANA INTO THE PROCEDURES

       FOR BUDDY-AID. WHEN AN INDIVIDUAL HAS BEEN EXPOSED TO SUFFICIENT

       NERVE AGENT SO THAT HE CAN NO LONGER HELP HIMSELF, HE REQUIRES BUDDY

       AID. SEVERE NERVE AGENT CASUALTIES WHO CANNOT INJECT

       THEMSELVES ARE GIVEN THEIR THREE ANTIDOTE SETS (ATROPINE AND 2 PAM

       CHLORIDE) IN RAPID SUCCESSION BY A BUDDY. WHEN A CASUALTY'S THIRD

       SET IS ADMINISTERED BY HIS BUDDY, THE BUDDY WILL THEN ADMINISTER THE












                                           UNCLASSIFIED          2212OOZOCT90
Box ID = BX000000
Unit = G3 NBC SECTION  
Parent Organization = ARCENT          
Folder Title = CANA                                                                                            
Subject = USCENTCOM POLICY ON U.S. FORCES USE OF DIAZEPAM
Document Number =         44
Image file name = 00000045.tif

Document Page: First | Prev | Next | All | Image | This Release | Search